[en] The histological assessment of atypical melanocytic neoplasms is mandatory to ensure proper diagnosis and treatment. However, for some atypical lesions, expert pathologists report only moderate concordance in the diagnosis. In addition, certain atypical neoplasms have been coined differently in the literature. These designations include among others atypical and metastasizing Spitz tumor, malignant Spitz naevus, borderline and intermediate melanocytic tumor, and melanocytic tumor of uncertain malignant potential (MELTUMP) or Spitzoid melanocytic tumor of uncertain malignant potential (STUMP). These neoplasms are grouped here under the heading melanocytoma. Such melanocytic lesions have a benign outcome but exhibit an atypical and worrisome aspect. Rare individual cases of melanocytomas can progress to locoregional disease (agminate melanocytomas), and even beyond. At times, the distinction between melanocytoma and melanoma is difficult and may even be impossible. However, multipronged immunohistochemistry can help define malignancy risk stratification and therapeutic guidelines.
Disciplines :
Dermatology
Author, co-author :
Quatresooz, Pascale ; Centre Hospitalier Universitaire de Liège - CHU > Dermatopathologie
Pierard, Claudine ; Centre Hospitalier Universitaire de Liège - CHU > Dermatopathologie
Pierard, Gérald ; Centre Hospitalier Universitaire de Liège - CHU > Dermatopathologie
Language :
English
Title :
Highlighting the immunohistochemical profile of melanocytomas: review.
Smoller BR: Histologic criteria for diagnosing primary cutaneous malignant melanoma. Modern Pathol 19: 34-40, 2006.
Darier J and Civatte A: Naevus ou naevo-carcinome chez un nourisson. Bull Soc Franc Derm Syph 21: 61-63, 1910.
Barnhill RL: The spitzoid lesion: rethinking Spitz tumors, atypical variants, 'spitzoid melanoma' and risk assessment. Modern Pathol 19: S21-S33, 2006.
Quatresooz P, Arrese JE, Piérard-Franchimont C and Piérard GE: Immunohistochemical aid at risk stratification of melanocytic neoplasms. Int J Oncol 24: 211-216, 2004.
Moi WJ and Krausz T: Spitz nevus versus spitzoid melanoma. Diagnostic difficulties, conceptual controversies. Adv Anat Pathol 13: 147-156, 2006.
Farmer ER and Gonin R: Discordance in the histopathologic diagnosis of melanoma and melanocytic nevi between expert pathologists. Hum Pathol 27: 528-531, 1996.
Grant-Kels JM, Bason ET and Grin CM: The misdiagnosis of malignant melanoma. J Am Acad Dermatol 4: 539-548, 1999.
Brochez L, Verhaeghe E, Grosshans E, et al: Inter-observer variation in the histopathological diagnosis of clinically suspicious pigmented skin lesions. J Pathol 196: 459-466, 2002.
Ainsworth AM, Folberg R, Reed RJ and Clark WH: Melanocytic Nevi, Melanocytomas, Melanocytic Dysplasias and Uncommon Forms of Melanoma. In: Human Malignant Melanoma: Clinical Oncology Monographs. Clark WH, Goldman KI and Mastrangelo MJ (eds). Grime & Stratton, New York, pp167-208, 1979.
Gurbuz Y, Apaydin R, Muezzinoglu B and Buyukbabani N: A case report and a current dilemma in histopathology: atypical Spitz nevus or spitzoid melanoma. Pediatr Dermatol 19: 99-102, 2002.
Mones JM and Ackerman AB: 'Atypical' Spitz's nevus, 'malignant' Spitz's nevus, and 'metastasizing' Spitz's nevus: A critique in historical perspective of three concepts flawed fatally. Am J Dermatopathol 26: 310-333, 2004.
Lee JB: Spitz nevus versus melanoma: limitation of the diagnostic methodology exposed. Eur J Dermatol 16: 223-224, 2006.
Piérard GE, Piérard-Franchimont C, Nikkels AF, et al.: Naevocyte triggering by recombinant human growth hormone. J Pathol 180: 74-79, 1996.
Onsun N, Saracoglu S, Demirkesen C, et al: Eruptive widespread Spitz nevi: can pregnancy be a stimulating factor? J Am Acad Dermatol 40: 866-867, 1999.
Sabroe RA, Vaingankar NV, Rigby HS and Peachey RD: Agminate Spitz naevi occurring in an adult after the excision of a solitary Spitz naevus: Report of a case and review of the literature. Clin Exp Dermatol 21: 197-200, 1996.
Ball NJ and Golitz LE: Melanocytic naevi with focal atypical epithelioid cell components: a review of seventy-three cases. J Am Acad Dermatol 40: 724-729, 1994.
Collina G, Deen S, Cliff S, et al: Atypical dermal nodules in benign melanocytic naevi. Histopathology 31: 97-101, 1997.
Quatresooz P, Uhoda I, Fumal I, et al: Revisiting the gender-linked melanoma burden. Dermatology 209: 197-201, 2004.
Uhoda I, Quatresooz P, Fumal I, et al: Updating trends in cutaneous cancers in south-east Belgium. Oncol Rep 12: 111-114, 2004.
Orchard DC, Dowling JP and Kelly JW: Spitz naevi misdiagnosed histologically as melanoma: prevalence and clinical profile. Aust J Dermatol 38: 12-14, 1997.
Barnhill RL, Argenyi ZB, From L, et al: Atypical Spitz nevi/ tumors: lack of consensus for diagnosis, discrimination from melanoma, and prediction of outcome. Hum Pathol 30: 513-520, 1999.
Alonso SR, Ortiz P, Pollan M, et al: Progression in cutaneous malignant melanoma is associated with distinct expression profiles. A tissue microarray-based study. Am J Pathol 164: 193-203, 2004.
Coulson A, Ross JS, Slominski A, et al: Molecular diagnostics in melanoma. J Am Acad Dermatol 52: 743-775, 2005.
Claessens N, Piérard GE, Piérard-Franchimont C, et al: Immunohistochemical detection of incipient melanoma micrometastases. Relationship with sentinel lymph node involvement. Melanoma Res 15: 107-110, 2005.
Crowson N, Magro CM and Mihm MC: Prognosticators of melanoma, the melanoma report, and the sentinel lymph node. Modern Pathol 10: S71-S87, 2006.
Piérard-Franchimont C, Henry F, Heymans O and Piérard GE: Vascular retardation in dormant growth-stunted malignant melanomas. Int J Mol Med 4: 403-406, 1999.
Kanter-Lewensohn L, Hedblad MA, Wejde J and Llqarsson O: Immunohistochemical markers for distinguishing Spitz nevi from malignant melanomas. Mod Pathol 10: 917-920, 1997.
Mangini J, Li N and Bhawan J: Immunohistochemical markers of melanocytic lesions. A review of their diagnostic usefulness. Am J Dermatopathol 24: 270-281, 2002.
Piérard-Franchimont C, Letawe C, Nikkels AF and Piérard GE: Patterns of the immunohistochemical expression of melanocyte-differentiation antigens and density of CD45RO+ T lymphocytes and L1-protein + macrophages in primary cutaneous melanomas. Int J Mol Med 2: 721-724, 1998.
Piérard-Franchimont C, Arrese JE, Nikkels AF, et al: Factor XIIIa-positive dermal dendrocytes and proliferative activity of cutaneous cancers. Virchows Arch 429: 43-48, 1996.
Quatresooz P and Piérard GE: Immunohistochemical investigation of α1 (IV) and α5 (IV) collagen chains in a broad spectrum of melanocytic tumours. Melanoma Res 15: 161-168, 2005.
Bergman R, Dromi R, Trau H, et al: The pattern of HMB-45 antibody staining in compound Spitz nevi. Am J Dermatopathol 17: 542-546, 1995.
Piérard GE, Piérard-Franchimont C, Henry C and Lapière M: The proliferative activity of cells of malignant melanomas. Am J Dermatopathol 6: S317-S324, 1984.
Spatz A, Calonje E, Handfield-Johnes S, et al: Spitz tumors in children: a grading system for risk stratification. Arch Dermatol 135: 282-285, 1999.
Walsh N, Crotty K, Palmer A, et al: Spitz nevus versus spitzoid malignant melanoma: An evaluation of the current distinguishing histopathologic criteria. Hum Pathol 29: 1105-1112, 1998.
Li LX, Crotty KA, McCarthy SW, et al: A zonal comparison of MIB1-Ki67 immunoreactivity in benign and malignant melanocytic lesions. Am J Dermatopathol 22: 489-495, 2000.
Bergman R, Malkin L, Sabo E, et al: MIB-1 monoclonal antibody to determine proliferative activity of Ki-67 antigen as an adjunct to histopathologic differential diagnosis of Spitz nevi. J Am Acad Dermatol 44: 500-504, 2001.
Vollmer RT: Use of Bayes rule and MIB-1 proliferation index to discriminate Spitz nevus from malignant melanoma. Am J Clin Pathol 122: 499-505, 2004.
Kapor P, Selim MA, Roy LC, et al: Spitz nevi and atypical Spitz nevi/tumors: a histologic and immunohistochemical analysis. Mod Pathol 18: 197-204, 2005.
Sprecher E, Bergman R, Meilick A, et al: Apoptosis, Fas and Fas-ligand expression in melanocytic tumors. Cutan Pathol 26: 72-77, 1999.
Hussein M, Haemel A and Wood ES: Apoptosis and melanoma: molecular mechanisms. J Pathol 199: 275-288, 2003.
Piérard GE and Piérard-Franchimont C: Stochastic relationship between the growth fraction and vascularity of thin malignant melanomas. Eur J Cancer 33: 1888-1892, 1997.
Heymans O, Blacher S, Brouers F and Piérard GE: Fractal quantification of the microvasculature heterogeneity in cutaneous melanoma. Dermatology 198: 212-217, 1999.
Bayer-Garner IB, Hough AJ and Smoller BR: Vascular endothelial growth factor expression in malignant melanoma: prognostic versus diagnostic usefulness. Mod Pathol 12: 770-774, 1999.
Cockerell CJ, Sonnier G, Kelly L and Patel S: Comparative analysis of neovascularization in primary cutaneous melanoma and Spitz nevus. Am J Dermatopathol 16: 9-13, 1994.
Diaz-Cascajo C, Borghi S and Weyers W: Angiomatoid Spitz nevus: a distinct variant of desmoplastic Spitz nevus with prominent vasculature. Am J Dermatopathol 22: 135-139, 2000.
